Effects of Aspirin on Clinical Outcomes of COVID-19: A Meta-Analysis
-
Published:2024
Issue:07
Volume:14
Page:901-911
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference32 articles.
1. Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
2. Formiga, F., Rubio-Rivas, M., Mora-Luján, J.M., et al. (2022) Does Admission Acetylsalicylic Acid Uptake in Hospitalized COVID-19 Patients Have a Protective Role? Data from the Spanish SEMI-COVID-19 Registry. Internal and Emergency Medicine, 17, 761-775.
3. RECOVERY Collaborative Group (2021) Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial. The Lancet, 397, 1637-1645.
4. Chow, J.H., Rahnavard, A., Gomberg-Maitland, M., et al. (2022) Association of Early Aspirin Use with In-Hospital Mortality in Patients with Moderate COVID-19. JAMA Network Open, 5, e223890.
5. Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study